Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Interactive Brokers Group Inc. Class A Common Stock (IBKR) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance

Interactive Brokers Group Inc. Class A Common StockTrade
Dr. Reddy's Laboratories Ltd Common StockTrade

Price performance (Past 24H)

Key statistics

Interactive Brokers Group Inc. Class A Common Stock vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Interactive Brokers Group Inc. Class A Common Stock trades at $83.75 (market cap $39.64B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Interactive Brokers Group Inc. Class A Common Stock is far larger — about 3.7× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays the higher dividend (0.65%). Which is the better fit depends on your goals — on Pluang, investors hold Interactive Brokers Group Inc. Class A Common Stock for 6 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.

IBKRRDY
Market Cap
$39.64B$10.78B
Volume
2,886,8052,724,343
Sector
FinancialsHealth
52-Week High
$98.19$15.38
52-Week Low
$61.05$11.38
Typical Hold Time
6 Days0 Days
Enterprise Value
$31.94B$10.68B
Dividend Yield
0.4%0.65%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Interactive Brokers Group Inc. Class A Common Stock

Interactive Brokers (IBKR) trades at $87.49, down 0.46% on the day, with technical indicators showing a bearish bias despite neutral oscillators. The company demonstrates strong fundamentals with revenue growth from $10.22B in 2025 to $11.1B projected for 2026, and net income rising from $984M to $1.1B. Recent earnings beats and expansion into cryptocurrency staking highlight ongoing business development, though valuation multiples appear elevated with a P/E of 34.72.

The outlook remains cautiously optimistic given analyst consensus pointing to 21% upside to the $106.11 price target, balanced by near-term technical weakness and stretched valuations. Key risks include competitive pressures in fintech and market volatility impacting trading volumes, while institutional sentiment shows mixed but generally positive positioning with 47% buy ratings.

Dr. Reddy's Laboratories Ltd Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IBKR

No sentiment data available yet.

RDY
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Interactive Brokers Group Inc. Class A Common Stock

Interactive Brokers operates an electronic brokerage platform for trading stocks, options, futures, currencies, and other assets. It also provides clearing and custody services.

Read more on IBKR →

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →